These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10070511)

  • 41. Effect of intraoperative injection of 0.25% bupivacaine with 1:200,000 epinephrine on intraoperative blood loss in FESS.
    Javer AR; Gheriani H; Mechor B; Flamer D; Genoway K; Yunker WK
    Am J Rhinol Allergy; 2009; 23(4):437-41. PubMed ID: 19671263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of dexmedetomidine infusion in patients undergoing functional endoscopic sinus surgery under local anaesthesia.
    Goksu S; Arik H; Demiryurek S; Mumbuc S; Oner U; Demiryurek AT
    Eur J Anaesthesiol; 2008 Jan; 25(1):22-8. PubMed ID: 17666131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of low and high frequency ranges for heart rate variability and blood pressure variability analyses using pharmacological autonomic blockade with atropine and propranolol in swine.
    Poletto R; Janczak AM; Marchant-Forde RM; Marchant JN; Matthews DL; Dowell CA; Hogan DF; Freeman LJ; Lay DC
    Physiol Behav; 2011 May; 103(2):188-96. PubMed ID: 21281655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic effects of an intraosseous injection of 2% lidocaine with 1:100,000 epinephrine.
    Chamberlain TM; Davis RD; Murchison DF; Hansen SR; Richardson BW
    Gen Dent; 2000; 48(3):299-302. PubMed ID: 11199596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissociation between haemodynamics and sympathetic activation during anaesthetic induction with desfluranes.
    Leung JM; Pastor DA
    Can J Anaesth; 1998 Jun; 45(6):533-40. PubMed ID: 9669006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subconjunctival 0.1% epinephrine versus placebo in maintenance of mydriasis during vitrectomy: a randomized controlled trial.
    de Araújo RB; Azevedo BMS; Andrade TS; Abalem MF; Monteiro MLR; Carricondo PC
    Int J Retina Vitreous; 2018; 4():38. PubMed ID: 30349740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Form of the femoral pulse and its changes due to pharmacological effect.
    JUNGMANN H; ROHR H
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1953; 258(1):47-57. PubMed ID: 13145262
    [No Abstract]   [Full Text] [Related]  

  • 48. Adverse effects of subconjunctival injections of mydriatic agents.
    Hartstein I; Deutsch N
    Br J Ophthalmol; 1991 Apr; 75(4):253. PubMed ID: 2021598
    [No Abstract]   [Full Text] [Related]  

  • 49. [The cycloplegic action of a mydriatic].
    STEINER C
    Bull Soc Ophtalmol Fr; 1961; 5():334-6. PubMed ID: 13916718
    [No Abstract]   [Full Text] [Related]  

  • 50. [Biological studies on a new synthetic mydriatic].
    BRAND I; TAKATS I
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1953; 122(5):576-84. PubMed ID: 13085684
    [No Abstract]   [Full Text] [Related]  

  • 51. Ocular penetration of procaine following subconjunctival injection.
    SCHLEGEL HE; SWAN KC
    AMA Arch Ophthalmol; 1954 Nov; 52(5):774-8. PubMed ID: 13206509
    [No Abstract]   [Full Text] [Related]  

  • 52. [A trial of new diagnostic mydriatic].
    MITSUI Y; MIKI T
    Nihon Ganka Kiyo; 1961 Dec; 12():1026. PubMed ID: 14474722
    [No Abstract]   [Full Text] [Related]  

  • 53. RO 1-7683/15: a new and effective mydriatic.
    NANO HM; GAVARINI O; PEREZ HA
    Am J Ophthalmol; 1960 May; 49():958-67. PubMed ID: 14425969
    [No Abstract]   [Full Text] [Related]  

  • 54. The mydriatic response of mice to atropine.
    QUINTON RM
    J Pharm Pharmacol; 1963 Apr; 15():239-50. PubMed ID: 13972794
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment attempt with subconjunctival autologous blood injections].
    NEMETZ U
    Wien Klin Wochenschr; 1949 Aug; 61(32):512. PubMed ID: 18229134
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics.
    Wu WM; Buchwald P; Mori N; Ji F; Wu J; Bodor N
    Pharm Res; 2005 Dec; 22(12):2035-44. PubMed ID: 16170596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics.
    Huang F; Browne CE; Wu WM; Juhász A; Ji F; Bodor N
    Pharm Res; 2003 Oct; 20(10):1681-9. PubMed ID: 14620526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemodynamic responses to subconjunctival mydriatic agents (Mydricaine) used for maintenance of perioperative mydriasis in patients undergoing vitreoretinal surgery.
    Jayamanne DG; Ray-Chaudhuri N; Wariyar R; Cottrell DG
    Eye (Lond); 1998; 12 ( Pt 5)():792-4. PubMed ID: 10070511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incidence of systemic side-effects following subconjunctival Mydricaine no. 1 injection.
    Steel DH; Thorn J
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():720-2. PubMed ID: 10707131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial fibrillation following subconjunctival injection of mydricaine number 02.
    Keembiyage RD; Raymond GL; Newland HS
    Clin Exp Ophthalmol; 2006 Nov; 34(8):806-8. PubMed ID: 17073912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.